Labshake search
Citations for R&D Systems :
801 - 850 of 1676 citations for Recombinant Rat Csf2 Protein since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... 10 ng/ml rat ciliary neurotrophic factor (CNTF; R&D Systems), 0.1 ng/ml rat glial cell line-derived neurotrophic factor (GDNF ...
-
bioRxiv - Cancer Biology 2020Quote: ... or rat IgG isotype control antibody (R&D Systems, clone 43414) 1 day prior to intracardiac injection of RM1-BoM3 prostate cancer bone metastasis cells ...
-
bioRxiv - Cell Biology 2022Quote: ... Rat monoclonal anti-IL-22ra1 (1:200, R&D systems, MAB42341); Goat polyclonal anti-tdTomato (1:500 ...
-
bioRxiv - Immunology 2020Quote: ... then incubated with rat anti-insulin antibody (182410; R&D Systems) overnight at 4°C ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: The Proteome Profiler Rat Adipokine Array Kit (ARY016, R&D Systems) was used to analyze molecular changes in cell culture media according to the manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2021Quote: ... Scgb1a1 (rat anti-human, R&D systems, MAB4218, 1:50 amplified), Scgb1a1 (rabbit anti-mouse ...
-
bioRxiv - Cell Biology 2021Quote: ... Rat anti-human SCGB1A1/CC10 (1:200, R&D system, MAB4218), Rabbit anti-KDR/VEGFR2 (1:100 ...
-
bioRxiv - Neuroscience 2023Quote: ... rat anti-O1 AF700 (1:100, FAB1327N-100UG; R&D Systems). Cells were washed twice ...
-
bioRxiv - Cancer Biology 2023Quote: ... or rat IgG (Cat. No. Mab006, R&D System, Minneapolis, MN) at 0.25 mg/mice via TVI for 3 weeks ...
-
bioRxiv - Immunology 2023Quote: ... rat anti-mouse CCR1 (25 µg/ml; mab5986, R&D Systems), rat anti-mouse-CCR5 (10 µg/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... and rat anti-Axl-AlexaFluor700 (R&D Systems, FAB8541N, 1:200). Secondary antibodies were used as follows ...
-
bioRxiv - Cell Biology 2023Quote: ... rat anti-Tyro3/Dtk-AlexaFluor700 (R&D Systems, FAB759N, 1:200), rat anti-Mertk-AlexaFluor700 (R&D Systems ...
-
bioRxiv - Molecular Biology 2023Quote: ... Mouse/Rat CD31/PECAM-1 antibody (R&D Systems, MN, USA), and SR-BI Antibody - BSA free (Novus Biologicals ...
-
bioRxiv - Physiology 2024Quote: ... and Leptin ELISA (Quantikine Mouse/Rat Leptin Immunoassay, R&D Systems) followed manufacturer’s protocols ...
-
bioRxiv - Cancer Biology 2021Quote: ... the cells were treated with recombinant human IFNγ (R&D Systems, 285-IF-100) by adding an equal volume of the complete culture media containing the cytokine ...
-
bioRxiv - Neuroscience 2020Quote: ... and human recombinant FGF2 (10 ng/ml, R&D Systems, Minneapolis, Minnesota; 233-FB). After two to three weeks ...
-
bioRxiv - Cell Biology 2019Quote: ... Recombinant human TGF-β (7754-BH) was purchased from R&D Systems (Minneapolis, MI). It was reconstituted at 100 μg/mL in sterile 4 mM HCl containing at least 0.1% BSA ...
-
bioRxiv - Cell Biology 2020Quote: ... during 2 hours and stimulated with human recombinant VEGF165 (25ng/ml, R&D System) during 30 minutes.
-
bioRxiv - Genomics 2019Quote: ... 50 ng/mL carrier-free recombinant human stem cell factor (SCF; R&D Systems), 50 ng/mL TPO (R&D Systems) ...
-
bioRxiv - Developmental Biology 2020Quote: ... cells were treated with 100ng/mL human recombinant FGF4 (R&D Systems, 235-F4) in the presence of 10 μg/mL heparin sulfate and 3 μM BI-D1870 RSK inhibitor at 37°C ...
-
bioRxiv - Neuroscience 2021Quote: ... where the medium was supplemented with recombinant Netrin (100 ng/ml, R&D Systems).
-
bioRxiv - Neuroscience 2020Quote: ... NMPM: N2B27 supplemented with 40 ng/ml recombinant human (rh) FGF2 (R&D Systems), 40 ng/ml rhFGF8 (R&D Systems) ...
-
bioRxiv - Developmental Biology 2019Quote: ... 0.1% of recombinant mouse Oncostatin M 10μg/ml (R&D Systems, #495-MO-025); 0.01% of recombinant human FGF basic protein 10μg/ml (R&D Systems ...
-
bioRxiv - Biochemistry 2019Quote: ... Human recombinant pro-legumain (asparaginyl endopeptidase) was purchased from R&D Systems (2199-CY), activated per manufacturer instruction and active site titrated using MP-L01 inhibitor as described by Poreba et al ...
-
bioRxiv - Bioengineering 2019Quote: ... 0.004 % of recombinant human FGF basic (FGF-2, R&D Systems, Abingdon, United Kingdom) was added ...
-
bioRxiv - Neuroscience 2019Quote: Recombinant human IDO (Accession #P14902) was obtained from R&D Systems (#6030-AO-010) and frozen at −80°C until use ...
-
bioRxiv - Cancer Biology 2019Quote: ... Recombinant human TGFβ-1 (cat# 240B002) was purchased from R&D systems (Minneapolis, MN). Alexa 488-conjugated phalloidin (cat# A12379 ...
-
bioRxiv - Immunology 2021Quote: ... recombinant human IL-4 at 50 ng/ml (R&D Systems, Minneapolis, MN, USA) for 6 h ...
-
bioRxiv - Bioengineering 2020Quote: ... and 2.5 ng mL−1 recombinant mouse FGF2 (R&D Systems # 3139-FB-025). In some experiments ...
-
bioRxiv - Bioengineering 2020Quote: ... and recombinant human IL-2 (50 U/mL, R&D Systems, Minneapolis, MN, USA). Single cell suspensions were activated with 1 μg/ml Concavalin A (Sigma ...
-
bioRxiv - Neuroscience 2020Quote: ... From day 10 the medium was supplemented with 3nM recombinant SHH (R&D Systems), 50ng/μl acidic fibroblast growth factor (αFGF ...
-
bioRxiv - Cancer Biology 2021Quote: ... Luciferase activity was confirmed using recombinant human TGFβ (R&D Systems, #240-B-010) treatment.
-
bioRxiv - Pharmacology and Toxicology 2020Quote: Recombinant human FGF23 and FGF2 were purchased from R&D Systems (Minneapolis, MN, USA). Synthetic human C-terminal FGF23 (residues 180-251 ...
-
bioRxiv - Cancer Biology 2020Quote: Murine recombinant FGF2 and IL-1β were acquired from R&D Systems (Minneapolis, MN). The proteinase K and Benzonase were purchased from Sigma-Aldrich ...
-
bioRxiv - Microbiology 2019Quote: ... An isotype control (Recombinant Human IgG1 Fc, CF; R&D Systems; 110-HG-100) and recombinant rotavirus NSP4 protein were used as controls respectively ...
-
bioRxiv - Molecular Biology 2022Quote: ... Recombinant human WNT3A and R-spondin 3 were from R&D Systems (Minneapolis, USA).
-
bioRxiv - Immunology 2022Quote: ... supplemented with 30 U/mL recombinant human IL-2 (R&D Systems #202-IL), and 55 μM beta- mercaptoethanol (Thermo # 21985023) ...
-
Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson’s diseasebioRxiv - Neuroscience 2020Quote: ... 100 ng/ml recombinant human sonic hedgehog (SHH) (R&D systems, 464-SH-025CF), 2 μM purmorphamine (Reprocell ...
-
bioRxiv - Cell Biology 2019Quote: ... Recombinant mouse IFNγ and β were purchased from R&D Systems (Minneapolis, MN, USA) Q-VD-OPh and ZVAD were purchased from MP Biomedicals (Seven Hills ...
-
bioRxiv - Physiology 2020Quote: ... at concentrations between 1-100 nM or recombinant human sclerostin (rhSCL) (R&D Systems) at concentrations between 1-50 ng/ml [28 ...
-
bioRxiv - Pathology 2021Quote: ... 1% Antibiotic-Antimycotic and 20ng/ml recombinant fibroblast growth factor 2 (R&D Systems)) and passaged using Accutase (Innovative Cell Technologies)19 ...
-
bioRxiv - Cancer Biology 2019Quote: ... In groups treated with recombinant mouse CCN4 (rmCCN4, 1680-WS-050, R&D Systems), rmCCN4 was added at a final concentration of 5.0µg/ml.
-
bioRxiv - Immunology 2019Quote: ... overnight before addition of 500 IU/ml recombinant human IL-2 (R&D Systems).
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Biochemistry 2020Quote: ... Recombinant human MMP-2 (902-MP-010) was purchased from R&D systems (USA). Recombinant human MMP-3 (SRP7783 ...
-
bioRxiv - Biochemistry 2021Quote: ... Treatments with human recombinant 10 ng/ml TGF-β1 (R&D Systems, Minneapolis, MN) were performed after serum-free starvation for 12 hours (h).
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Developmental Biology 2021Quote: ... were embedded in a Bmp7 solution (R&D systems, Recombinant Human BMP7 #354-BP) in PBS ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant human TGFβ and Universal Type I IFN was obtained from R&D Systems.
-
Immunoresolvents Support Skeletal Myofiber Regeneration via Actions on Myeloid and Muscle Stem CellsbioRxiv - Immunology 2020Quote: ... and human recombinant GM-CSF (20 ng/mL) (R&D Systems, 215-GM-010). Cells then were washed with PBS to remove non-adherent cells and detached by incubation in TrypLE Select at 37°C followed by gentle cell scraping ...